Analysis Article • Jul 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 20, 2026
DataAggregated Company Financials
Companies6
- 7D-1.0%
- 3M-26.8%
- 1Y-25.9%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 1.0%, driven by Dingdang Health Technology Group declining 4.3%. Overall the industry is down 26% in 12 months. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 Jul 2026 | HK$192.3b | HK$143.1b | HK$8.7b | 30.3x | 22.1x | 1.3x |
| Wed, 17 Jun 2026 | HK$193.2b | HK$143.3b | HK$8.7b | 32.2x | 22.1x | 1.3x |
| Fri, 15 May 2026 | HK$254.5b | HK$141.3b | HK$8.7b | 41.8x | 29.3x | 1.8x |
| Sun, 12 Apr 2026 | HK$270.3b | HK$140.4b | HK$8.6b | 46.6x | 31.3x | 1.9x |
| Tue, 10 Mar 2026 | HK$272.0b | HK$138.7b | HK$7.7b | 38.3x | 35.5x | 2x |
| Thu, 05 Feb 2026 | HK$332.4b | HK$128.7b | HK$6.9b | 46.4x | 48.2x | 2.6x |
| Sat, 03 Jan 2026 | HK$302.8b | HK$127.5b | HK$6.8b | 39.1x | 44.3x | 2.4x |
| Mon, 01 Dec 2025 | HK$324.8b | HK$125.9b | HK$6.7b | 42.4x | 48.2x | 2.6x |
| Wed, 29 Oct 2025 | HK$334.3b | HK$122.5b | HK$6.2b | 61.3x | 54.3x | 2.7x |
| Fri, 26 Sep 2025 | HK$369.2b | HK$122.2b | HK$6.1b | 67.1x | 60.1x | 3x |
| Sun, 24 Aug 2025 | HK$341.3b | HK$121.9b | HK$5.2b | 56.8x | 65.2x | 2.8x |
| Tue, 22 Jul 2025 | HK$261.9b | HK$115.4b | HK$4.5b | 48.3x | 58.1x | 2.3x |
| Thu, 19 Jun 2025 | HK$233.8b | HK$115.2b | HK$4.5b | 47x | 51.9x | 2x |
| Sat, 17 May 2025 | HK$238.5b | HK$112.0b | HK$4.2b | 64.5x | 56.4x | 2.1x |
| Mon, 14 Apr 2025 | HK$208.4b | HK$110.0b | HK$4.1b | 58.3x | 50.2x | 1.9x |
| Wed, 12 Mar 2025 | HK$229.5b | HK$108.0b | HK$5.3b | 48.7x | 43.5x | 2.1x |
| Fri, 07 Feb 2025 | HK$182.1b | HK$103.8b | HK$3.6b | 42x | 50.7x | 1.8x |
| Sun, 05 Jan 2025 | HK$147.6b | HK$103.3b | HK$3.6b | 35.3x | 41.3x | 1.4x |
| Tue, 03 Dec 2024 | HK$173.5b | HK$104.0b | HK$3.6b | 39.4x | 48.2x | 1.7x |
| Thu, 31 Oct 2024 | HK$172.0b | HK$104.6b | HK$3.3b | 48.8x | 51.8x | 1.6x |
| Sat, 28 Sep 2024 | HK$186.7b | HK$106.3b | HK$3.4b | 51.2x | 55.4x | 1.8x |
| Mon, 26 Aug 2024 | HK$132.3b | HK$104.9b | HK$3.3b | 36.3x | 39.8x | 1.3x |
| Wed, 24 Jul 2024 | HK$136.4b | HK$101.7b | HK$2.4b | 41.8x | 57.2x | 1.3x |
| Fri, 21 Jun 2024 | HK$151.3b | HK$101.9b | HK$2.4b | 45.9x | 63.4x | 1.5x |
| Sun, 19 May 2024 | HK$170.5b | HK$103.7b | HK$2.3b | 50.7x | 73.3x | 1.6x |
| Tue, 16 Apr 2024 | HK$138.7b | HK$103.8b | HK$2.3b | 41.5x | 59.5x | 1.3x |
| Thu, 14 Mar 2024 | HK$174.8b | HK$105.1b | -HK$1,456,509,455.21 | 58x | -120x | 1.7x |
| Sat, 10 Feb 2024 | HK$163.3b | HK$105.1b | -HK$1,482,861,775.89 | 52.1x | -110.1x | 1.6x |
| Mon, 08 Jan 2024 | HK$188.5b | HK$105.8b | -HK$1,465,349,501.00 | 58.4x | -128.6x | 1.8x |
| Wed, 06 Dec 2023 | HK$205.2b | HK$105.8b | -HK$1,465,836,294.00 | 64.4x | -140x | 1.9x |
| Fri, 03 Nov 2023 | HK$205.5b | HK$101.8b | -HK$1,735,605,163.00 | 86.2x | -118.4x | 2x |
| Sun, 01 Oct 2023 | HK$230.3b | HK$102.5b | -HK$1,677,457,985.00 | 101.5x | -137.3x | 2.2x |
| Tue, 29 Aug 2023 | HK$236.0b | HK$102.2b | -HK$1,953,899,230.00 | 75.3x | -120.8x | 2.3x |
| Thu, 27 Jul 2023 | HK$282.0b | HK$96.5b | -HK$4,187,878,686.00 | 125.9x | -67.3x | 2.9x |
Price to Earnings Ratio
-67.3x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.1x which is lower than its 3-year average PE of 98.6x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 0.25% | |
| Consumer Staples | 4.16% | |
| Food and Staples Retail | 0.32% | |
| Drug Retail | -1.01% | |
| Big Box Super Stores | 7.22% | |
| Food Retail | 2.12% | |
| Food Distributors | -3.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$38.28 | 4.3% +HK$5.0b | -20.7% | PE19.6x | |
| 241 Alibaba Health Information Technology | HK$3.45 | 3.0% +HK$1.6b | -26.6% | PE24.9x | |
| 1833 Ping An Healthcare and Technology | HK$7.66 | 2.4% +HK$382.8m | -21.1% | PE37.1x | |
| 6086 Fangzhou | HK$0.84 | 18.3% +HK$180.1m | -78.1% | PE84.9x | |
| 2290 Lung Fung Group Holdings | HK$3.74 | 3.6% +HK$65.0m | n/a | PE11x |